Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

June 1st, 2004

View Archives Issues

  • Experts offer blueprint for improving a research staff education program

    For clinical trials administrators and investigators who desire best practices in human subjects protection, there can be no better place to start than with research staff education. Education and training of research staff and investigators traditionally was provided in the form of a mentoring program in which a junior person learned from a senior person, says Ruth Fischbach, PhD, MPE, director of the Center for Bioethics at Columbia University in New York City.
  • Learning can go beyond traditional classroom

    Sometimes, the best teaching strategy is one in which the student is not even aware that he or she is a student. At least thats the approach that one research educational program has tried and found to be successful. What I find useful in these situations is to try to recruit investigators to be instructors, says Ruth Fischbach, PhD, MPE, director of the Center for Bioethics at Columbia University in New York City.
  • NIH’s genetic info data system goes on-line

    The Genetic Modification Clinical Research Information System (GeMCRIS), a web-based data system designed to assist researchers and others involved in human gene therapy studies, manages information about science and safety of clinical trials in this field. Three years in development, the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) jointly launched GeMCRIS at the end of March.
  • Canadian group studies ethical use of placebos

    When should placebos be used in clinical research? Can subjects with a medical condition be asked to consent to withdraw from their current medications and take an experimental medication with the 50/50 chance that what they actually receive will be no medication at all?
  • Cancer researcher calls for trial process changes

    During a presentation at the 2004 Annual Scientific Congress of the Royal Australasian College of Surgeons, held May 2-7 in Melbourne, Australia, Jonathan Lewis, MD, PhD, a former cancer researcher at Memorial Sloan-Kettering Cancer Center in New York City and the New Haven, CT-based Yale University School of Medicine, called for changes in oncology clinical trial design.
  • CTA Calendar